Predicting and preventing hospital readmission for exacerbations of COPD

More than a third of patients hospitalised for acute exacerbation of COPD are readmitted to hospital within 90 days. Healthcare professionals and service providers are expected to collaboratively drive efforts to improve hospital readmission rates, which can be challenging due to the lack of clear c...

Full description

Bibliographic Details
Main Authors: Chia Wei Kong, Tom M.A. Wilkinson
Format: Article
Language:English
Published: European Respiratory Society 2020-05-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/6/2/00325-2019.full
_version_ 1818279672889212928
author Chia Wei Kong
Tom M.A. Wilkinson
author_facet Chia Wei Kong
Tom M.A. Wilkinson
author_sort Chia Wei Kong
collection DOAJ
description More than a third of patients hospitalised for acute exacerbation of COPD are readmitted to hospital within 90 days. Healthcare professionals and service providers are expected to collaboratively drive efforts to improve hospital readmission rates, which can be challenging due to the lack of clear consensus and guidelines on how best to predict and prevent readmissions. This review identifies these risk factors, highlighting the contribution of multimorbidity, frailty and poor socioeconomic status. Predictive models of readmission that address the multifactorial nature of readmissions and heterogeneity of the disease are reviewed, recognising that in an era of precision medicine, in-depth understanding of the intricate biological mechanisms that heighten the risk of COPD exacerbation and re-exacerbation is needed to derive modifiable biomarkers that can stratify accurately the highest risk groups for targeted treatment. We evaluate conventional and emerging strategies to reduce these potentially preventable readmissions. Here, early recognition of exacerbation symptoms and the delivery of prompt treatment can reduce risk of hospital admissions, while patient education can improve treatment adherence as a key component of self-management strategies. Care bundles are recommended to ensure high-quality care is provided consistently, but evidence for their benefit is limited to date. The search continues for interventions which are effective, sustainable and applicable to a diverse population of patients with COPD exacerbations. Further research into mechanisms that drive exacerbation and affect recovery is crucial to improve our understanding of this complex, highly prevalent disease and to advance the development of more effective treatments.
first_indexed 2024-12-12T23:37:04Z
format Article
id doaj.art-b83bd6ca815244b2942def25b5515ebe
institution Directory Open Access Journal
issn 2312-0541
language English
last_indexed 2024-12-12T23:37:04Z
publishDate 2020-05-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj.art-b83bd6ca815244b2942def25b5515ebe2022-12-22T00:07:23ZengEuropean Respiratory SocietyERJ Open Research2312-05412020-05-016210.1183/23120541.00325-201900325-2019Predicting and preventing hospital readmission for exacerbations of COPDChia Wei Kong0Tom M.A. Wilkinson1 Southampton NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK Southampton NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK More than a third of patients hospitalised for acute exacerbation of COPD are readmitted to hospital within 90 days. Healthcare professionals and service providers are expected to collaboratively drive efforts to improve hospital readmission rates, which can be challenging due to the lack of clear consensus and guidelines on how best to predict and prevent readmissions. This review identifies these risk factors, highlighting the contribution of multimorbidity, frailty and poor socioeconomic status. Predictive models of readmission that address the multifactorial nature of readmissions and heterogeneity of the disease are reviewed, recognising that in an era of precision medicine, in-depth understanding of the intricate biological mechanisms that heighten the risk of COPD exacerbation and re-exacerbation is needed to derive modifiable biomarkers that can stratify accurately the highest risk groups for targeted treatment. We evaluate conventional and emerging strategies to reduce these potentially preventable readmissions. Here, early recognition of exacerbation symptoms and the delivery of prompt treatment can reduce risk of hospital admissions, while patient education can improve treatment adherence as a key component of self-management strategies. Care bundles are recommended to ensure high-quality care is provided consistently, but evidence for their benefit is limited to date. The search continues for interventions which are effective, sustainable and applicable to a diverse population of patients with COPD exacerbations. Further research into mechanisms that drive exacerbation and affect recovery is crucial to improve our understanding of this complex, highly prevalent disease and to advance the development of more effective treatments.http://openres.ersjournals.com/content/6/2/00325-2019.full
spellingShingle Chia Wei Kong
Tom M.A. Wilkinson
Predicting and preventing hospital readmission for exacerbations of COPD
ERJ Open Research
title Predicting and preventing hospital readmission for exacerbations of COPD
title_full Predicting and preventing hospital readmission for exacerbations of COPD
title_fullStr Predicting and preventing hospital readmission for exacerbations of COPD
title_full_unstemmed Predicting and preventing hospital readmission for exacerbations of COPD
title_short Predicting and preventing hospital readmission for exacerbations of COPD
title_sort predicting and preventing hospital readmission for exacerbations of copd
url http://openres.ersjournals.com/content/6/2/00325-2019.full
work_keys_str_mv AT chiaweikong predictingandpreventinghospitalreadmissionforexacerbationsofcopd
AT tommawilkinson predictingandpreventinghospitalreadmissionforexacerbationsofcopd